In particular, the significant increase in plasma proteasome content in CML patients who also had increased PaCSs as well as increased proteasome content in their leukemic cells suggests that release of UPS-rich PaCS content is a source of plasma proteasome. Here, HMBS is linked to chronic myelogenous leukemia, BCR-ABL1 positive.